Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Sarasota, Florida 34239


Purpose:

The purpose of this study is to evaluate the effectiveness of Focal-Fusion Bx at detecting clinically significant prostate cancer in a standard clinical environment.


Study summary:

The objective of this study is to determine the effectiveness of the Focal-Fusion Bx device at finding clinically relevant prostate cancer. A multiparametric MRI examination will be carried out prior to study enrollment. Probable cancerous regions (regions of interest, ROI) will be identified, and these ROIs will be used as targets during the biopsy. Three prostate sampling methods will be conducted in the same session on all patients. These include: i) Focal-Fusion Bx targeted biopsy ii) Cognitive fusion targeted biopsy and iii) Systematic (untargeted) biopsy. Trans-rectal ultrasound (TRUS) imaging will be conducted with BK Flex Focus Ultrasound system (Analogic Corporation, Peabody, MA). Primary hypothesis: The technique used to acquire the biopsy samples will impact the proportion of clinically relevant cancers by improving the specificity of detecting clinically significant cancers. It is hypothesized that Focal-Fusion Bx biopsies will diagnose more high risk cancers and fewer low-risk cancers than non-targeted systematic biopsies.


Criteria:

Inclusion Criteria: - Adult male subjects up to 80 years of age - Candidates for fusion biopsy - Elevated PSA levels - MP-MRI with lesions having a Prostate Imaging Reporting and Data System (PI-RADS) score greater than or equal to 3 (determined by a trained radiologist) - Subject is willing and able to read, understand and sign the Informed Consent Form document Exclusion Criteria: - Previous treatment for prostate cancer - Any contraindication to a standard TRUS prostate biopsy procedure - Refusal to sign the Informed Consent document


NCT ID:

NCT02524860


Primary Contact:

Principal Investigator
Winston Barzell, MD
21st Century Oncology, Inc.


Backup Contact:

N/A


Location Contact:

Sarasota, Florida 34239
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.